Article Versions Notes

Zhang Y, Yao Q, Pan Y, Fang X, Xu H, Zhao T, Zhu G, Jiang T, Li S, Cao H. Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review. Cancers. 2023; 15(3):682. https://doi.org/10.3390/cancers15030682

Zhang, Yiru, Qigu Yao, Yong Pan, Xinru Fang, Haoying Xu, Tingxiao Zhao, Guangqi Zhu, Tianan Jiang, Shibo Li, and Hongcui Cao. 2023. "Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review" Cancers 15, no. 3: 682. https://doi.org/10.3390/cancers15030682

Zhang, Y., Yao, Q., Pan, Y., Fang, X., Xu, H., Zhao, T., Zhu, G., Jiang, T., Li, S., & Cao, H. (2023). Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review. Cancers, 15(3), 682. https://doi.org/10.3390/cancers15030682